MarketCapTrends
AGPU
Predictive Oncology Inc. (AGPU)
NASDAQ · Technology

Predictive Oncology Inc. Shareholder Equity 2017–2025

Predictive Oncology Inc. annual/quarterly shareholder equity history from 2017 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Predictive Oncology Inc. shareholder equity for the quarter ending December 31, 2025 were 47.7M, a 23651.14% decrease year-over-year.
  • Predictive Oncology Inc. shareholder equity for 2025 were 47.7M, a 23651.14% decrease from 2024.
  • Predictive Oncology Inc. shareholder equity for 2024 were -202,610, a 102.45% decrease from 2023.
  • Predictive Oncology Inc. shareholder equity for 2023 were 8.3M, a 0.00% increase from 2022.
  • Predictive Oncology Inc. shareholder equity for 2022 were 8.3M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Predictive Oncology Inc. Annual Shareholder Equity (Millions of US $)
2025$48
2024$-0
2023$8
2022$8
2021$40
2020$3
2019$11
2018$0
2017$3
Predictive Oncology Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$48
2024-12-31$-0
2023-12-31$8
2022-12-31$8
2021-12-31$40
2020-12-31$3
2019-12-31$11
2018-12-31$0
2017-12-31$3

Predictive Oncology Inc. Shareholder Equity — FAQ

Predictive Oncology Inc. (AGPU) shareholder equity over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see AGPU's shareholder equity history?

The chart and table above show Predictive Oncology Inc.'s shareholder equity by year and by quarter, including the growth rate.